Risk factors for a low linezolid trough plasma concentration in acute infections

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 4, 2013, Pages 1913-1917

  Morata, Laura ^a   Cuesta, Marta ^a   Rojas, Jhon F ^a   Rodriguez, Sebastian ^a   Brunet, Merce ^a   Casals, Gregori ^a   Cobos, Nazareth ^a   Hernandez, Cristina ^a   Martínez, José A ^a   Mensa, Josep ^a   Soriano, Alex ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID;

ADULT; ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; FEMALE; GLOMERULUS FILTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STAPHYLOCOCCUS INFECTION; STEADY STATE;

ACETAMIDES; ADULT; AGED; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OXAZOLIDINONES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84875151104     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01694-12     Document Type: Article

References (23)

1. Livermore DM. 2003. Linezolid in vitro: mechanism and antibacterial spectrum. J. Antimicrob. Chemother. 51(Suppl 2):ii9-ii16.
2. Falagas ME, Siempos II, Vardakas KZ. 2008. Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials. Lancet Infect. Dis. 8:53-66.
3. Wunderink RG, Niederman MS, Kollef MH, Shorr AF, Kunkel MJ, Baruch A, McGee WT, Reisman A, Chastre J. 2012. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin. Infect. Dis. 54:621-629.
4. Craig WA. 2003. Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid. Infect. Dis. Clin. North Am. 17:479-501.
5. Rayner CR, Forrest A, Meagher AK, Birmingham MC, Schentag JJ. 2003. Clinical pharmacodynamics of linezolid in seriously ill patients treated in a compassionate use programme. Clin. Pharmacokinet. 42: 1411-1423.
6. Pea F, Furlanut M, Cojutti P, Cristini F, Zamparini E, Franceschi L, Viale P. 2010. Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis. Antimicrob. Agents Chemother. 54:4605-4610.
7. Foj Capell L, Soriano Viladomiu A, Brunet Serra M, López Galera RM. 2011. Determinación de linezolid en plasma mediante cromatografía líquida de 11 alta resolución para la monitorización terapéutica en pacientes. Rev. Lab. Clin. 4:207-213.
8. Adembri C, Fallani S, Cassetta MI, Arrigucci S, Ottaviano A, Pecile P, Mazzei T, De Gaudio R, Novelli A. 2008. Linezolid pharmacokinetic/ pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion. Int. J. Antimicrob. Agents 31:122-129.
9. Thallinger C, Buerger C, Plock N, Kljucar S, Wuenscher S, Sauermann R, Kloft C, Joukhadar C. 2008. Effect of severity of sepsis on tissue concentrations of linezolid. J. Antimicrob. Chemother. 61:173-176.
10. Taccone FS, Laterre PF, Dugernier T, Spapen H, Delattre I, Witebolle X, De Backer D, Layeux B, Wallemacq P, Vincent JL, Jacobs F. 2010. Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock. Crit. Care 14:R126. doi:10.1186/cc9091.
11. Udy AA, Roberts JA, Lipman J. 2011. Implications of augmented renal clearance in critically ill patients. Nat. Rev. Nephrol. 7:539-543.
12. Tsuji Y, Hiraki Y, Mizoguchi A, Hayashi W, Kamohara R, Kamimura H, Karube Y. 2008. Pharmacokinetics of repeated dosing of linezolid in a hemodialysis patient with chronic renal failure. J. Infect. Chemother. 14: 156-160.
13. Tsuji Y, Hiraki Y, Matsumoto K, Mizoguchi A, Kobayashi T, Sadoh S, Morita K, Kamimura H, Karube Y. 2011. Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunction. J. Infect. Chemother. 17:70-75.
14. Wu V-C, Wang Y-T, Wang C-Y, Tsai I-J, Wu K-D, Hwang J-J, Hsueh P-R. 2006. High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease. Clin. Infect. Dis. 42:66-72.
15. Lin Y-H, Wu V-C, Tsai I-J, Ho Y-L, Hwang J-J, Tsau Y-K, Wu C-Y, Wu K-D, Hsueh P-R. 2006. High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency. Int. J. Antimicrob. Agents 28:345-351.
16. Gerson SL, Kaplan SL, Bruss JB, Le V, Arellano FM, Hafkin B, Kuter DJ. 2002. Hematologic effects of linezolid: summary of clinical experience. Antimicrob. Agents Chemother. 46:2723-2726.
17. Plock N, Buerger C, Joukhadar C, Kljucar S, Kloft C. 2007. Does linezolid inhibit its own metabolism? Population pharmacokinetics as a tool to explain the observed nonlinearity in both healthy volunteers and septic patients. Drug Metab. Dispos. 35:1816-1823.
18. Soriano A, Miró O, Mensa J. 2005. Mitochondrial toxicity associated with linezolid. N. Engl. J. Med. 353:2305-2306.
19. Levey AS, Stevens LA, Schmid C, Zang Y, Alejando C, Feldman H, Kusek J, Eggers P, Van Lente F, Greene T, Coresh J. 2009. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150: 604.
20. Park EJ, Wu K, Mi Z, Dong T, Lawrence JP, Ko CW, Huang SM, Zhang L, Crentsil V, Zhang J, Xu NN. 2012. A systematic comparison of Cockcroft-Gault and modification of diet in renal disease equations for classification of kidney dysfunction and dosage adjustment. Ann. Pharmacother. 46:1174-1187.
21. Jones RN, Kohno S, Ono Y, Ross JE, Yanagihara K. 2009. ZAAPS International Surveillance Program (2007) for linezolid resistance: results from 5591 Gram-positive clinical isolates in 23 countries. Diagn. Microbiol. Infect. Dis. 64:191-201.
22. Boselli E, Breilh D, Caillault-Sergent A, Djabarouti S, Guillaume C, Xuereb F, Bouvet L, Rimmelé T, Saux MC, Allaouchiche B. 2012. Alveolar diffusion and pharmacokinetics of linezolid administered in continuous infusion to critically ill patients with ventilator-associated pneumonia. J. Antimicrob. Chemother. 67:1207-1210.
23. Tascini C, Bongiorni MG, Doria R, Polidori M, Iapoce R, Fondelli S, Tagliaferri E, Soldati E, Di Paolo A, Leonildi A, Menichetti F. 2011. Linezolid for endocarditis: a case series of 14 patients. J. Antimicrob. Chemother. 66:679-682.